Late Effects after Allogeneic Hematopoietic Cell Transplantation Among Children and Adolescents with Non-Malignant Disorders: A Report from the Center for International Blood and Marrow Transplant Research (CIBMTR)
Justine M. Kahn(Columbia University Irving Medical Center), Prakash Satwani(Pediatrics and Genetics), Betty K. Hamilton(Cleveland Clinic), David Buchbinder(Children's Hospital of Orange County), Ruta Brazauskas(Medical College of Wisconsin), Hélène Schoemans(KU Leuven), Rachel Phelan(Children's Hospital of Wisconsin), Stephanie Bo‐Subait(National Marrow Donor Program)
Cited by 0
Related Papers
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
|Bone Marrow Transplantation|2018|479
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States
|Blood|2017|296